News

Rural Care Reimagined: Avel eCare Multipoint EMS Model Supports Stronger Hospitals and Communities

SIOUX FALLS, SD / ACCESS Newswire / December 9, 2025 / When a medical emergency happens in rural America, distance,…

2 weeks ago

Alliance for Paired Kidney Donation (APKD) Launches Wish Upon a Donor: A Hope-Focused Advocacy Program Helping Kids Who Need Kidneys Find Living Donors

TOLEDO, OHIO / ACCESS Newswire / December 9, 2025 / The Alliance for Paired Kidney Donation (APKD) is proud to…

2 weeks ago

Results from Phase 1 Multiple-Dose Study of PT00114

Findings support advancement into Phase 2 to explore a first-in-class pathway aimed at stress-related neuropsychiatric conditions NEW YORK CITY, NEW…

2 weeks ago

Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025

100% of patients in Cohorts 1-3 remain free of cytokine release syndromeCRIS-7-derived CD3 design underpins a controlled T-cell response, supporting…

2 weeks ago

Vheda Health Named a 2025 Top Workplace in Metro Area by the Baltimore Sun

COLUMBIA, MARYLAND / ACCESS Newswire / December 9, 2025 / Vheda Health has been awarded a Top Workplaces 2025 honor…

2 weeks ago

Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid

~ Engineered to Deliver Potent Pain Relief with Unique, Built-In, Abuse Protection ~ SAN DIEGO, CA / ACCESS Newswire /…

2 weeks ago

AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA’s DNA-Guided Biofeedback Wellness Ecosystem

This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and…

2 weeks ago

Novo Nordisk has completed its acquisition of Akero Therapeutics

Bagsværd, Denmark and South San Francisco, CA, US, 9 December 2025 – Novo Nordisk and Akero Therapeutics Inc. (“Akero”) (Nasdaq:…

2 weeks ago

Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer

Data highlights the ability of Akari’s Trop2 ADC, AKTX-101, to kill K-Ras G12V mutated cancer cell lines in preclinical models,…

2 weeks ago

Aleen Inc. Introduces Wellness AI: A Journey into Self-Discovery, Not Medical Diagnosis

Toronto, Ontario--(Newsfile Corp. - December 9, 2025) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, invites users to explore…

2 weeks ago